Biotechnology
Compare Stocks
2 / 10Stock Comparison
XAGE vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
XAGE vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Medical - Healthcare Plans |
| Market Cap | $7M | $335.60B |
| Revenue (TTM) | $1M | $449.71B |
| Net Income (TTM) | $-6M | $12.04B |
| Gross Margin | 54.6% | 18.8% |
| Operating Margin | -401.0% | 4.2% |
| Forward P/E | — | 20.2x |
| Total Debt | $639K | $78.39B |
| Cash & Equiv. | $157K | $24.36B |
XAGE vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Longevity Health Ho… (XAGE) | 100 | 0.1 | -99.9% |
| UnitedHealth Group … (UNH) | 100 | 94.6 | -5.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XAGE vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XAGE is the clearest fit if your priority is growth exposure.
- Rev growth 139.4%, EPS growth 32.4%
- 139.4% revenue growth vs UNH's 11.8%
UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- 220.6% 10Y total return vs XAGE's -99.9%
- Lower volatility, beta 0.59, Low D/E 77.1%, current ratio 0.79x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 139.4% revenue growth vs UNH's 11.8% | |
| Quality / Margins | 2.7% margin vs XAGE's -393.6% | |
| Stability / Safety | Beta 0.59 vs XAGE's 1.86 | |
| Dividends | 2.4% yield; 25-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -3.2% vs XAGE's -92.6% | |
| Efficiency (ROA) | 3.9% ROA vs XAGE's -173.9%, ROIC 9.2% vs -38.0% |
XAGE vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
XAGE vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 308591.6x XAGE's $1M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to XAGE's -3.9%. On growth, XAGE holds the edge at +19.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1M | $449.7B |
| EBITDAEarnings before interest/tax | -$6M | $23.2B |
| Net IncomeAfter-tax profit | -$6M | $12.0B |
| Free Cash FlowCash after capex | -$4M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +54.6% | +18.8% |
| Operating MarginEBIT ÷ Revenue | -4.0% | +4.2% |
| Net MarginNet income ÷ Revenue | -3.9% | +2.7% |
| FCF MarginFCF ÷ Revenue | -2.6% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +19.8% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.9% | +0.7% |
Valuation Metrics
Evenly matched — XAGE and UNH each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $7M | $335.6B |
| Enterprise ValueMkt cap + debt − cash | $7M | $389.6B |
| Trailing P/EPrice ÷ TTM EPS | -0.64x | 27.95x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 16.70x |
| Price / SalesMarket cap ÷ Revenue | 133.03x | 0.75x |
| Price / BookPrice ÷ Book value/share | — | 3.31x |
| Price / FCFMarket cap ÷ FCF | — | 20.88x |
Profitability & Efficiency
UNH leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-103 for XAGE. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs XAGE's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -103.5% | +11.5% |
| ROA (TTM)Return on assets | -173.9% | +3.9% |
| ROICReturn on invested capital | -38.0% | +9.2% |
| ROCEReturn on capital employed | -47.5% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | — | 0.77x |
| Net DebtTotal debt minus cash | $481,854 | $54.0B |
| Cash & Equiv.Liquid assets | $157,139 | $24.4B |
| Total DebtShort + long-term debt | $638,993 | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | -293.50x | 4.71x |
Total Returns (Dividends Reinvested)
UNH leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UNH five years ago would be worth $9,743 today (with dividends reinvested), compared to $11 for XAGE. Over the past 12 months, UNH leads with a -3.2% total return vs XAGE's -92.6%. The 3-year compound annual growth rate (CAGR) favors UNH at -7.1% vs XAGE's -89.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +6.4% | +10.6% |
| 1-Year ReturnPast 12 months | -92.6% | -3.2% |
| 3-Year ReturnCumulative with dividends | -99.9% | -19.9% |
| 5-Year ReturnCumulative with dividends | -99.9% | -2.6% |
| 10-Year ReturnCumulative with dividends | -99.9% | +220.6% |
| CAGR (3Y)Annualised 3-year return | -89.8% | -7.1% |
Risk & Volatility
UNH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than XAGE's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 93.5% from its 52-week high vs XAGE's 3.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.86x | 0.59x |
| 52-Week HighHighest price in past year | $8.27 | $395.52 |
| 52-Week LowLowest price in past year | $0.23 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +3.9% | +93.5% |
| RSI (14)Momentum oscillator 0–100 | 48.5 | 75.9 |
| Avg Volume (50D)Average daily shares traded | 1K | 7.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
UNH is the only dividend payer here at 2.35% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $385.43 |
| # AnalystsCovering analysts | — | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% |
| Dividend StreakConsecutive years of raises | — | 25 |
| Dividend / ShareAnnual DPS | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.7% |
UNH leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.
XAGE vs UNH: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is XAGE or UNH a better buy right now?
UnitedHealth Group Incorporated (UNH) offers the better valuation at 27.
9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — XAGE or UNH?
Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.
6%, compared to -99. 9% for Longevity Health Holdings Inc. (XAGE). Over 10 years, the gap is even starker: UNH returned +220. 6% versus XAGE's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — XAGE or UNH?
By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.
59β versus Longevity Health Holdings Inc. 's 1. 86β — meaning XAGE is approximately 216% more volatile than UNH relative to the S&P 500.
04Which is growing faster — XAGE or UNH?
On earnings-per-share growth, the picture is similar: Longevity Health Holdings Inc.
grew EPS 32. 4% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — XAGE or UNH?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -206. 1% for Longevity Health Holdings Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -99. 3% for XAGE. At the gross margin level — before operating expenses — XAGE leads at 87. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — XAGE or UNH?
In this comparison, UNH (2.
4% yield) pays a dividend. XAGE does not pay a meaningful dividend and should not be held primarily for income.
07Is XAGE or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +220. 6% 10Y return). Longevity Health Holdings Inc. (XAGE) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UNH: +220. 6%, XAGE: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between XAGE and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
UNH pays a dividend while XAGE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.